» Articles » PMID: 19833514

The Design of Potent and Selective Inhibitors of DPP-4: Optimization of ADME Properties by Amide Replacements

Overview
Specialty Biochemistry
Date 2009 Oct 17
PMID 19833514
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

For a series of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV ADME properties were improved by the incorporation of amide replacements. These efforts led to a novel series of potent and selective inhibitors of DPP-4 that exhibit an attractive pharmacokinetic profile and show excellent efficacy in an animal model of diabetes.

Citing Articles

Synthetic Approaches to Novel DPP-IV Inhibitors-A Literature Review.

Petrov V, Aleksandrova T, Pashev A Molecules. 2025; 30(5).

PMID: 40076268 PMC: 11902039. DOI: 10.3390/molecules30051043.


Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents.

Mohammad B, Baig M, Bhandari N, Siddiqui F, Khan S, Ahmad Z Molecules. 2022; 27(18).

PMID: 36144735 PMC: 9502781. DOI: 10.3390/molecules27186001.


Design, synthesis and cytotoxic evaluation of a library of oxadiazole-containing hybrids.

Camacho C, Pizzio M, Roces D, Boggian D, Mata E, Bellizzi Y RSC Adv. 2022; 11(47):29741-29751.

PMID: 35479556 PMC: 9040754. DOI: 10.1039/d1ra05602f.


Design, Synthesis and Biological Evaluation of Neogliptin, a Novel 2-Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4).

Maslov I, Zinevich T, Kirichenko O, Trukhan M, Shorshnev S, Tuaeva N Pharmaceuticals (Basel). 2022; 15(3).

PMID: 35337071 PMC: 8949241. DOI: 10.3390/ph15030273.


Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Kumari S, Carmona A, Tiwari A, Trippier P J Med Chem. 2020; 63(21):12290-12358.

PMID: 32686940 PMC: 7666045. DOI: 10.1021/acs.jmedchem.0c00530.